Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- What Lilly Learned From Steak n Shake: A Q&A on Cymbalta
- Eli Lilly’s Cymbalta is fast adding indications. Today the company announced the results of a trial to see if the drug can be used for back pain and last week it was approved in Europe for generalized anxiety disorder. Its wide variety of uses --...
- Blog posts 2008-08-25
Additional Resources
- Sanofi-Aventis' Ambien CR ads skirt new DTC rules
- WITH JUST MONTHS of patent life left on its original Ambien, Sanofi-Aventis kicked off DTC for Ambien CR zolpidem tartrate last month with a 15secondTV reminder ad, a 60-second spot and a coupon for a free seven-day trial.
- Research articles 2005-12-01
- Is Pfizer's Sleeping Pill Obsession Running up King Stock?
- Trading in options on King Pharmaceuticals shares reached a four-year frenzy yesterday, Reuters reported, and King shares rose to an 11-month high on rumors that Pfizer may be interested in acquiring it. Pfizer pfollowers know that CEO Jeff Kindler made a lot of noise a few years...
- Blog posts 2008-08-06
- Shire's Big Gamble on ADHD Drug Vyvanse
- One of the recent unheralded successes of the drug world was Shire Pharmaceuticals' launch of Vyvanse, a new, long-acting treatment for attention deficit and hyperactivity disorder. The fact that so little attention has been paid to Vyvanse is a shame because the take-up of this drug has been impressive --...
- Blog posts 2008-09-04
- Insomnia and Antidepressant Sales Give Lie to DTC Myths
- Direct-to-consumer drug advertising has almost no relationship with consumer demand for prescriptions. That is one interpretation of a story in Ad Age showing that scrips for insomnia pills (such as Sanofi-Aventis's Ambien CR) and antidepressants (such as Eli Lilly's Cymbalta) are up, even though advertising in both those categories is...
- Blog posts 2009-03-05
- Ask Your Doctor If This Ad Is Right for You
- By Arlene Weintraub Does it seem like you hear the phrase "ask your doctor" every time you turn on the TV? There's a reason. Drug companies spend about $5 billion a year in the U.S. on ads imploring people to talk to their physicians if they think a pill they've...
- News items 2009-11-05
- WALGREEN PROGNOSIS: A DROP-OFF IN GENERICS; Blockbuster knockoffs, a key revenue source, set to dwindle in 2008.(News)
- Byline: MONEE FIELDS-WHITE The steady flow of blockbuster generic drugs that's boosted sales and profit at Walgreen Co. in the past two years is poised to slow. Generic versions of drugs like sleep aid Ambien and blood-pressure medicine Norvasc Byline:...
- Research articles 2007-07-09
- Five new prescription drugs are nearing approval from the FDA.(HEALTH)
- Five new prescription drugs are nearing approval from the FDA. All are potential blockbusters, helping drug firms replace profits lost because of expired patents on Zocor, Ambien and other popular drugs. Five new prescription drugs are nearing approval from the FDA. All are potential...
- Research articles 2007-05-04
- Insomnia Pill Makers Go After Elderly With New 'Fear of Falling'
- For years, drug companies have tried to expand the range of prescriptions of sleeping pills. They're not just for sleeping any more -- now they're also for avoiding "rebound insomnia" in the elderly, "increased risk of automotive crashes, decreased work performance ... or mood changes," generalized anxiety disorder, and depression....
- Blog posts 2008-09-11
- Neurogen Corporation Q4 2007 Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions Our first question comes from the line of Katherine Xu - Credit Suisse. Katherine Xu - Credit Suisse Stephen, I was just wondering with regards to the Phase 2/3 study of Ambien versus, or adipiplon versus Ambien CR there’s...
- Earnings calls 2008-03-19
- Sanofi Joins Pfizer in Drug-Based Video Game Business
- Sanofi-Aventis has become the latest drug company to get into the online video game business. This time, it's for its ubiquitous sleeping pill, Ambien CR. The game is called "Silence Your Rooster." The game is part of Sanofi's ad campaign for Ambien, which the Wall Street Journal...
- Blog posts 2008-09-25
- Sepracor Announces 940 Layoffs; Achieves the Impossible on Lunesta Sales
- Back in August, BNET ragged on Sepracor for implementing a cost-cutting program that drove up its expenses and drove down its revenue. In its Q4 earnings today, the company has turned that all around -- sales are up and expenses are down. The turnaround has come at...
- Blog posts 2009-01-29
- How Drug Advertising Restrictions Could Benefit the Industry
- The drug business spends $5 billion a year on advertising and yet studies continue to emerge suggesting that hundreds of millions of those dollars are wasted. Perhaps it's time to consider whether more restrictions on drug ads might, counterintutively, benefit the industry. ...
- Blog posts 2009-11-05
- Physicians' samples prescribe blisters: a new packaging line at Sanofi-Aventis' St. Louis plant produces two-unit blister-packs of Ambien supplied to physicians to hand out as samples.(pharmaceutical packs)
- Sanofi-Aventis is the world's third-largest pharmaceutical company, with facilities in more than 100 countries. Its plant in St. Louis is strictly a packaging operation that runs products brought in from other Sanofi operations as well as from thir Sanofi-Aventis is the world's third-largest pharmaceutical...
- Research articles 2006-04-01
- Toprol-XL tops price hikes, says AARP
- TOPROL-XL takes the cake for price increases, followed closely by Ambien. according to AARP.
- Research articles 2006-05-01
- Sanofi-Aventis' nightmares over ... for now
- SENSATIONAL IF largely anecdotal tales of insomniacs gorging themselves in their sleep after taking Ambien doubtless caused Sanofi-Aventis some sleepless nights, but the PR nightmare quickly passed.
- Research articles 2006-05-01
- Sanofi-Aventis VP touts value of CRM
- IN AN EVER-changing marketplace, pharma marketers must always be working on ways to foster patient relationships, according to the marketing VP behind Sanofi-Aventis' blockbuster Ambien CR.
- Research articles 2006-12-01
- Research and Markets: This New Report Covers Any OTC or Prescription Remedy in the US Today Marketed Specifically for Sleep Such as Nytol, Sominex, or Ambien
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c56967) has announced the addition of Sleep Aids in the United States 2006 to their offering
- Research articles 2007-05-16
- Painful Surprises and Big Lessons with Precious Metals & Energy
- Marc Courtenay submits: Thursday evening, before I went to bed here on the west coast of the US, I decided to look at the current precious metals spot prices in Asia. Big mistake and a good thing I have a prescription of AMBIEN CR from my doctor which I...
- External links 2008-08-17
- New Media Opportunity for Drug Firms: Video Games
- Perhaps you're tired of seeing the same healthy-looking people in drug ads hiking across craggy rocks or picking up their grandkids or wafting gently off to sleep while a slew of side effects (in fine print, natch) scrolls quickly by. If so, the pharmaceutical industry has another offer for you:...
- Blog posts 2008-09-25
- << Previous
- page 1 of 1
- Next >>
